Search
There are 4950 result(s) for cardiomyopathy
-
Research identifies new ways to try and prevent lethal blood clots
Scientists we fund have made a breakthrough in understanding the process that leads to a blood clot forming in the lungs - a condition that kills more than two thousand people in the UK each year.
-
PUBLICATION
ICD - your quick guideBooklet, 16 pages, published on 01/05/2014
This short illustrated leaflet explains how an ICD - or implantable cardioverter defibrillator works and answers some common questions about everyday life.
Free to order and currently in stock.
View online Download (1.3 MB)
Want to order more?
This publication maximum quantity order is 400. Get in touch and we can help if you want to order over the maximum allowed quantities of any booklet or guide. -
Standing with our BHF research community
Coronavirus (Covid-19) is an unprecedented pandemic that has shaken the world. As the situation evolves, we are mobilising our research community to join the fight against Covid-19.
-
Leading charity CEOs warn of damage to research caused by Covid-19 pandemic
The pace of discovering life saving treatments is being threatened by the financial impact of the Covid-19 pandemic on charities, we are warning today in a comment for a leading scientific journal.
-
Can air pollution kill you?
Toxic air is all around us, even when we can't see it. But don’t let its invisibility fool you - BHF research has shown that fine particulate matter known as PM2.5 is a triple threat. We explore just how exactly air pollutants can harm your health, and how our work aims to protect peoples' health.
-
Stroke - LACI-2 trial
Lacunar stroke is caused by damage to small blood vessels deep in the brain, and can ultimately lead to dementia. LACI-2 explored whether isosorbide mononitrate and cilostazol could be used to treat lacunar stroke.
-
BHF responds to Autumn Statement
The BHF has responded to the Government's Autumn Statement.
-
Blood pressure drugs could protect against type 2 diabetes
Lowering high blood pressure is an effective way to reduce a person’s risk of developing type 2 diabetes in the future, according to research we've funded and published in The Lancet.